![Lior Teitelbaum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lior Teitelbaum
Direktor/Vorstandsmitglied bei Protekt Therapeutics Ltd.
Aktive Positionen von Lior Teitelbaum
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
![]() Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Private Equity Investor | 01.02.2022 | - |
A2i Therapeutics Ltd.
![]() A2i Therapeutics Ltd. Investment ManagersFinance A2i Therapeutics Ltd. is an Israeli AI-based drug-design company that aims to develop novel therapeutic modulators of the protein ADAR1, a key element of the innate immune system. The company is a joint venture of the FutuRx Incubator and Atomwise, utilizing the AtomNet® AI platform and FutuRx’s technology to translate extraordinary technologies to life-changing therapies. | Direktor/Vorstandsmitglied | 01.01.2021 | - |
Protekt Therapeutics Ltd.
![]() Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Direktor/Vorstandsmitglied | - | - |
FutuRx Ltd.
![]() FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Corporate Officer/Principal | 01.01.2019 | - |
Karriereverlauf von Lior Teitelbaum
Ehemalige bekannte Positionen von Lior Teitelbaum
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pg Medical Systems Ltd. | Direktor/Vorstandsmitglied | 01.01.2018 | 01.01.2019 |
MindUP Ltd. | Gründer | 01.02.2016 | 01.12.2018 |
Corporate Officer/Principal | 01.02.2016 | 01.12.2018 | |
BIOLINERX LTD. | Private Equity Investor | 01.04.2012 | 01.05.2015 |
Corporate Officer/Principal | 01.06.2015 | 01.02.2016 | |
Metacure Israel Ltd. | Vertrieb & Marketing | 01.01.2010 | 01.01.2012 |
Ausbildung von Lior Teitelbaum
Tel-Aviv University | Masters Business Admin |
The Hebrew University of Jerusalem | Undergraduate Degree |
Weizmann Institute of Science | Graduate Degree |
Statistik
International
Israel | 11 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Private Equity Investor | 2 |
Sektoral
Finance | 4 |
Consumer Services | 4 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOLINERX LTD. | Health Technology |
Private Unternehmen | 7 |
---|---|
Johnson & Johnson Innovation - JJDC, Inc.
![]() Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
FutuRx Ltd.
![]() FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
Metacure Israel Ltd. | |
Protekt Therapeutics Ltd.
![]() Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Health Technology |
MindUP Ltd. | |
Pg Medical Systems Ltd. | |
A2i Therapeutics Ltd.
![]() A2i Therapeutics Ltd. Investment ManagersFinance A2i Therapeutics Ltd. is an Israeli AI-based drug-design company that aims to develop novel therapeutic modulators of the protein ADAR1, a key element of the innate immune system. The company is a joint venture of the FutuRx Incubator and Atomwise, utilizing the AtomNet® AI platform and FutuRx’s technology to translate extraordinary technologies to life-changing therapies. | Finance |
- Börse
- Insiders
- Lior Teitelbaum
- Erfahrung